The anticipation of a bearish reversal for stocks in Iliad follows on a technical rebound that started several trading sessions ago as well as return to important technical resistance levels. Investors should open a short trade and target the € 90.7.
In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The company has poor fundamentals for a short-term investment strategy.
The group's high margin levels account for strong profits.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
The group shows a rather high level of debt in proportion to its EBITDA.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The underlying tendency is negative on the weekly chart below the resistance at 112.05 EUR
The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.